ICER releases draft evidence report on therapies for severe asthma

16 September 2021 - Public comment period now open until 14 October 2021; requests to make oral comment during public ...

Read more →

ICER publishes evidence report on treatments for myasthenia gravis

10 September 2021 - While eculizumab and efgartigimod each provide important health benefits, both would need to be priced more than ...

Read more →

PBAC Public Summary Documents (first time decisions not to recommend, deferrals and other matters) – May 2021 meeting

10 September 2021 - The Public Summary Documents (first time decisions not to recommend, deferrals and other matters) from the May ...

Read more →

Public Summary Documents – May 2021 PBAC meeting

27 August 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2021 PBAC ...

Read more →

TGA reduces timeframe for publishing adverse event reports

19 August 2021 - With strong public interest in adverse event reports relating to COVID-19 vaccinations, and improvements in our ...

Read more →

ICER releases draft evidence report on mavacamten for hypertrophic cardiomyopathy

18 August 2021 - Public comment period now open until 15 September 2021; requests to make oral comment during public meeting ...

Read more →

ICER releases draft evidence report on therapies for myasthenia gravis

22 July 2021 - Public comment period now open until 18 August 2021; requests to make oral comment during public meeting ...

Read more →

Drug Utilisation Subcommittee outcome statement

21 July 2021 - The outcome statement from the June 2021 Drug Utilisation Subcommittee meeting is now available. ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) – March 2021 meeting

16 July 2021 - The Public Summary Documents (first time rejections and deferrals) from the March 2021 PBAC meeting are now ...

Read more →

DUSC utilisation analysis public release documents

13 July 2021 - The utilisation analysis public release documents from the February 2021 DUSC meeting are now available. ...

Read more →

ICER publishes evidence report on therapies for atopic dermatitis

9 July 2021 - Evidence demonstrates the JAK inhibitors abrocitinib and upadacitinib are effective treatments for atopic dermatitis, but safety concerns ...

Read more →

COVID-19 vaccine weekly safety report (8 July 2021)

8 July 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

PBAC Public Summary Document for risdiplam – March 2021 meeting

5 July 2021 - The Public Summary Document for risdiplam from the March 2021 PBAC meeting is now available. ...

Read more →

COVID-19 vaccine weekly safety report (27 May 2021)

27 May 2021 - Nine additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

COVID-19 vaccine weekly safety report

20 May 2021 - Six additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →